Treace Medical Concepts Inc (NAS:TMCI)
$ 7.9 -0.02 (-0.25%) Market Cap: 493.39 Mil Enterprise Value: 481.34 Mil PE Ratio: 0 PB Ratio: 4.69 GF Score: 51/100

Treace Medical Concepts Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 08:15PM GMT
Release Date Price: $29.99 (+8.27%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for turning -- tuning into another session of the Morgan Stanley Healthcare conference. I'm Drew Ranieri, one of the medical device analysts here. From Treace Medical, I'm excited to have CEO, John Treace; and CFO, Mark Hair with us this afternoon for a fireside chat.

Before we get into it, just a brief disclaimer. For important disclosures, go to www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

With that, John and Mark, thank you so much for your time today. Looking forward to the discussion. And I thought I would start this conversation a bit differently than some of the other ones at the conference. But just given that you're a newer company and your public company,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot